• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Deep Learning Model Predicts Liver Cancer Response to Immunotherapy Rechallenge

by
November 14, 2026
in Health, Technology
Reading Time: 3 mins read
0
Deep Learning Model Predicts Liver Cancer Response to Immunotherapy Rechallenge

Deep Learning Model Predicts Liver Cancer Response to Immunotherapy Rechallenge

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A combined artificial intelligence model integrating pretreatment computed tomography imaging features with clinical metrics can noninvasively predict tumor response and patient survival following immunotherapy rechallenge in hepatocellular carcinoma, according to a multicenter retrospective study.

While immunotherapy rechallenge is increasingly considered for patients following disease progression or the discontinuation of prior PD-1 inhibitor therapy, clinical decision-making has been hampered by a lack of reliable pretreatment tools.

To address this predictive challenge, researchers retrospectively evaluated 200 consecutive patients with hepatocellular carcinoma who underwent PD-1 inhibitor rechallenge between January 2020 and June 2025 across two medical centers. The primary development cohort comprised 157 patients from one institution, who were assigned via stratified random sampling in a 7:3 ratio into a training cohort of 109 patients and an internal testing cohort of 48 patients. An independent cohort of 43 patients from the second center served as an external validation cohort to assess generalizability.

The primary endpoint evaluated across all cohorts was objective response according to modified Response Evaluation Criteria in Solid Tumors. Across the development cohort of 157 patients, 26 individuals (16.56 percent) achieved an objective response upon immunotherapy rechallenge. To assess predictive utility, investigators constructed and compared three distinct pretreatment modeling strategies: a standalone clinical model, a three-dimensional deep learning feature model extracted from contrast-enhanced computed tomography, and an integrated combined clinical and three-dimensional deep learning model.

Across all evaluated cohorts, the combined clinical and three-dimensional deep learning logistic regression model demonstrated favorable predictive performance and calibration. In the training cohort, the combined model achieved an area under the receiver operating characteristic curve of 0.881 and a Brier score of 0.088, significantly outperforming the standalone clinical model (P = 0.007). In the internal testing cohort, the model recorded an area under the curve of 0.853 and a Brier score of 0.095, again demonstrating statistically significant superiority over clinical variables alone (P = 0.028).

In the independent external validation cohort, the combined model maintained solid discriminative accuracy, achieving an area under the curve of 0.804 and a Brier score of 0.130. Within this external cohort, the model demonstrated an overall diagnostic accuracy of 0.814, a sensitivity of 0.556, a specificity of 0.882, and a positive predictive value of 0.556. Decision curve analysis and calibration curves confirmed favorable clinical net benefit and risk alignment across the study cohorts.

In addition to predicting objective radiographic response, the combined model demonstrated a significant ability to stratify post-rechallenge survival outcomes. Patients stratified into favorable risk tiers by the model exhibited significantly longer progression-free survival, with a hazard ratio of 0.54 (P = 0.008), as well as improved overall survival, with a hazard ratio of 0.55 (P = 0.031). In survival stratification, the integrated model achieved higher discriminative performance than conventional clinical staging and scoring systems.

SHAP analysis identified AFP as the most influential predictor, together with multiple arterial- and venous-phase 3D deep learning features.

The study authors concluded that pretreatment models integrating clinical variables with contrast-enhanced computed tomography-derived three-dimensional deep learning features offer a promising decision-support tool for noninvasive response prediction and risk stratification. However, because the study design was retrospective and limited to 200 patients across two centers, the authors emphasized that further prospective multicenter validation is warranted before clinical implementation can occur.

Subject of Research: Pretreatment CT-based deep learning model for response prediction and survival stratification after immunotherapy rechallenge in hepatocellular carcinoma

Article Title: Pretreatment CT-based 3D deep learning feature model for predicting treatment response and stratifying survival after immunotherapy rechallenge in hepatocellular carcinoma

Article References: Li, Z., Lu, Z., Ye, C., Huang, R., & Zhang, L. (2026). Pretreatment CT-based 3D deep learning feature model for predicting treatment response and stratifying survival after immunotherapy rechallenge in hepatocellular carcinoma. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-026-03978-0

Image Credits: AI Generated

DOI: 10.1186/s12911-026-03978-0

Keywords: hepatocellular carcinoma, immunotherapy rechallenge, PD-1 inhibitors, deep learning, contrast-enhanced computed tomography, 3D deep learning, mRECIST, objective response, progression-free survival, overall survival, alpha-fetoprotein, external validation, receiver operating characteristic, Brier score, decision curve analysis, SHAP analysis, clinical decision support

News Source: Nathaniel Bowman. (November 14, 2026). Deep Learning Model Predicts Liver Cancer Response to Immunotherapy Rechallenge. Scienmag.

Tags: 3D deep learningalpha-fetoproteinBrier scoreClinical decision supportcontrast-enhanced computed tomographydecision curve analysisdeep learningexternal validationHepatocellular Carcinomaimmunotherapy rechallengemRECISTobjective responseoverall survivalPD-1 inhibitorsprogression-free survivalreceiver operating characteristicSHAP analysis
Share12Tweet7Share2ShareShareShare1

Related Posts

Rotavirus Vaccine Reduces Hospitalization for Laboratory-Confirmed Gastroenteritis in Southern Italy

Rotavirus Vaccine Reduces Hospitalization for Laboratory-Confirmed Gastroenteritis in Southern Italy

November 18, 2026
Clobazam Review Highlights Pharmacological Nuance and Polytherapy Dosing in Difficult Epilepsies

Clobazam Review Highlights Pharmacological Nuance and Polytherapy Dosing in Difficult Epilepsies

November 18, 2026

Fibroblast-Derived MDK Signaling Drives Lymph Node Metastasis in Luminal Breast Cancer

November 18, 2026

Pipelined Blockchain Protocol Boosts Sharding Throughput Nearly Threefold in Large Network Tests

November 18, 2026

POPULAR NEWS

  • Epilepsy Marks Lower Adaptive Functioning in Boys With MECP2 Duplication Syndrome

    Epilepsy Marks Lower Adaptive Functioning in Boys With MECP2 Duplication Syndrome

    29 shares
    Share 12 Tweet 7
  • Geno2pheno Overestimates CXCR4 Tropism in Chinese HIV-1 CRF01_AE Clinical Isolates

    29 shares
    Share 12 Tweet 7
  • Climate Variability Drives Growing Global Risks Across Foodborne Pathogen Pathways

    29 shares
    Share 12 Tweet 7
  • Catheter Drainage Reduces Surgical Burden While Endoscopy Accelerates Early Hemorrhage Clearance

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Physics-Embedded Artificial Intelligence Framework Enhances Flight Stability for Flapping-Wing Aerial Robots

Rotavirus Vaccine Reduces Hospitalization for Laboratory-Confirmed Gastroenteritis in Southern Italy

Clobazam Review Highlights Pharmacological Nuance and Polytherapy Dosing in Difficult Epilepsies

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.